Neuronal apoptosis and reversible motor deficit in dominant-negative GSK-3 conditional transgenic mice.
Ontology highlight
ABSTRACT: Increased glycogen synthase kinase-3 (GSK-3) activity is believed to contribute to the etiology of chronic disorders like Alzheimer's disease and diabetes, thus supporting therapeutic potential of GSK-3 inhibitors. However, sustained GSK-3 inhibition might induce tumorigenesis through beta-catenin-APC dysregulation. Besides, sustained in vivo inhibition by genetic means (constitutive knock-out mice) revealed unexpected embryonic lethality due to massive hepatocyte apoptosis. Here, we have generated transgenic mice with conditional (tetracycline system) expression of dominant-negative-GSK-3 as an alternative genetic approach to predict the outcome of chronic GSK-3 inhibition, either per se, or in combination with mouse models of disease. By choosing a postnatal neuron-specific promoter, her
SUBMITTER: Gomez-Sintes R
PROVIDER: S-EPMC1888681 | biostudies-literature | 2007 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA